Dalma Mangimi S.p.A. ("Regardia" or the "Group"), a portfolio company of the Nextalia Private Equity fund managed by Nextalia SGR S.p.A. ("Nextalia"), announces the signing of a binding agreement for the acquisition of 100% of the share capital of Animal Wellness Products S.p.A. ("AWP"), a leading player in the development and production of phytomolecules and additives based on essential oils, aimed at improving animal health by reducing the use of antibiotics and promoting sustainable animal welfare.

Founded in 2002 by Paolo Cristofori and based in Castelnuovo Rangone (Modena), AWP has established itself as a center of excellence thanks to its proprietary know-how, ongoing research and development efforts in collaboration with universities and international research centers, a long-term entrepreneurial vision, and the ability to operate internationally through strong commercial relationships. In recent years, AWP has consolidated its role as a key operator, reaching revenues of over €7 million, with more than 95% generated abroad, and an EBITDA margin exceeding 40%.

The transaction structure provides for the acquisition by Regardia of the entire share capital of AWP. Paolo Cristofori, founder and CEO of AWP, will reinvest in the Group by retaining a minority stake, confirming the strength of the project and his confidence in the future growth prospects of the new Group.

Vitale acted as financial advisor to the buyer.

n.a.